Literature DB >> 3903822

Sex steroids and affect in the surgical menopause: a double-blind, cross-over study.

B B Sherwin, M M Gelfand.   

Abstract

The effect of estrogen and/or androgen on mood in surgically menopausal women was investigated with a prospective, double-blind, cross-over design. Oophorectomized women who received either estrogen (E), androgen (A), or a combined estrogen-androgen preparation (E-A) parenterally attained lower depression scores during both treatment phases compared to a placebo group (PL), coincident with their higher plasma estrogen and testosterone levels. When steroids were withdrawn, depression scores of all oophorectomized women were significantly higher than those of a hysterectomized control group with intact ovaries (CON). The A group also had higher hostility scores than the E, PL, and CON groups. These data provide evidence of a covariation between circulating levels of estrogen and testosterone and certain affects in healthy women.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903822     DOI: 10.1016/0306-4530(85)90009-5

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  21 in total

1.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

Review 2.  Depression and the menopause.

Authors:  D Gath; S Iles
Journal:  BMJ       Date:  1990-05-19

Review 3.  Neuroendocrine effects on mood.

Authors:  Margaret G Spinelli
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

4.  Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

Authors:  B Saletu; N Brandstätter; M Metka; M Stamenkovic; P Anderer; H V Semlitsch; G Heytmanek; J Huber; J Grünberger; L Linzmayer
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 5.  Pharmacological therapy for female sexual dysfunction: has progress been made?

Authors:  Susan R Davis; Esme A Nijland
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women.

Authors:  Barbara B Sherwin; Miglena Grigorova
Journal:  Fertil Steril       Date:  2011-06-24       Impact factor: 7.329

7.  Women's views of two interventions designed to assist in the prophylactic oophorectomy decision: a qualitative pilot evaluation.

Authors:  Vanita Bhavnani; Aileen Clarke; Jack Dowie; Andrew Kennedy; Ian Pell
Journal:  Health Expect       Date:  2002-06       Impact factor: 3.377

8.  Body image and sexuality in oophorectomized women.

Authors:  S B Bellerose; Y M Binik
Journal:  Arch Sex Behav       Date:  1993-10

Review 9.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 10.  Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Authors:  Claudio N Soares; Jennifer R Poitras; Jennifer Prouty
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.